Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 31518174

Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2020 Feb 10
First author
Kim HA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Natl Med J India. 2020 Sep-Oct;33(5):289-290. doi: 10.4103/0970-258X.317474.
    note
    Source null
    related pmid
    34213458
    relationship
    Comment in

Authors and identifiers

  1. name
    Kim HA
    type
    Author
  2. name
    Lee JW
    type
    Author
  3. name
    Nam SJ
    type
    Author
  4. name
    Park BW
    type
    Author
  5. name
    Im SA
    type
    Author
  6. name
    Lee ES
    type
    Author
  7. name
    Jung YS
    type
    Author
  8. name
    Yoon JH
    type
    Author
  9. name
    Kang SS
    type
    Author
  10. name
    Lee SJ
    type
    Author
  11. name
    Park KH
    type
    Author
  12. name
    Jeong J
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Kim HA
    type
    Author
  2. name
    Lee JW
    type
    Author
  3. name
    Nam SJ
    type
    Author
  4. name
    Park BW
    type
    Author
  5. name
    Im SA
    type
    Author
  6. name
    Lee ES
    type
    Author
  7. name
    Jung YS
    type
    Author
  8. name
    Yoon JH
    type
    Author
  9. name
    Kang SS
    type
    Author
  10. name
    Lee SJ
    type
    Author
  11. name
    Park KH
    type
    Author
  12. name
    Jeong J
    type
    Author
bibliography ids
  1. nci-bib-6bd3e626cfe21c252c97cc5a
book metadata
content sha256
82e327982b7c9b393ece9095852f99328ff549546e9da0c667768f15398ec000
document type
citation
dois
  1. 10.1200/JCO.19.00126
electronic publication date
display
2019 Sep 16
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:31518174
immutable id
pubmed:31518174@82e327982b7c9b393ece9095852f99328ff549546e9da0c667768f15398ec000
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
5
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
434-443
volume
38
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Natl Med J India. 2020 Sep-Oct;33(5):289-290. doi: 10.4103/0970-258X.317474.
    note
    Source null
    related pmid
    34213458
    relationship
    Comment in
outcomes validated
false
pmid
31518174
provenance
batch id
23ffe1e2a9e160b6dca0
provider
NCBI PubMed ESummary
record sha256
e069cb3bb3dabecbd8bdf72555e7fb07ca8d38775cca75fb413fae952307e0fd
response sha256
d5cbfde8f87ba85b214c53aaf0e8fa33d70fec48dd4fde7745538180cd7e1841
retrieved at
2026-09-09T23:47:44.690737+00:00
publication date
display
2020 Feb 10
precision
day
year
2020
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/31518174/
title
Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III Trial.

Preserved source evidence · Not medical advice